Click for best price
Alpha1 Antitrypsin Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 1252.9 million
|
Forecast Market size by 2029 |
US$ 2152.6 million
|
| Growth Rate |
CAGR of 8.0% |
Number of Pages |
79 Pages |
This report aims to provide a comprehensive presentation of the global market for Alpha-1 Antitrypsin Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha-1 Antitrypsin Drugs. This report contains market size and forecasts of Alpha-1 Antitrypsin Drugs in global, including the following market information:
Global Alpha-1 Antitrypsin Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Alpha-1 Antitrypsin Drugs Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Alpha-1 Antitrypsin Drugs companies in 2022 (%)
The global Alpha-1 Antitrypsin Drugs market was valued at US$ 1252.9 million in 2022 and is projected to reach US$ 2152.6 million by 2029, at a CAGR of 8.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Parenteral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Alpha-1 Antitrypsin Drugs include Baxter, CSL Behring, Grifols, Kamada, Abeona Therapeutics, Alnylam Pharmaceuticals, Applied Genetic Technologies Corp, Arrowhead Research Corporation and Baxalta, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Alpha-1 Antitrypsin Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alpha-1 Antitrypsin Drugs Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Alpha-1 Antitrypsin Drugs Market Segment Percentages, by Type, 2022 (%)
Parenteral
Inhalation
Global Alpha-1 Antitrypsin Drugs Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Alpha-1 Antitrypsin Drugs Market Segment Percentages, by Application, 2022 (%)
Drugstore
Hospital
Others
Global Alpha-1 Antitrypsin Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Alpha-1 Antitrypsin Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alpha-1 Antitrypsin Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Alpha-1 Antitrypsin Drugs revenues share in global market, 2022 (%)
Key companies Alpha-1 Antitrypsin Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Alpha-1 Antitrypsin Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter
CSL Behring
Grifols
Kamada
Abeona Therapeutics
Alnylam Pharmaceuticals
Applied Genetic Technologies Corp
Arrowhead Research Corporation
Baxalta
Outline of Major Chapters:
Chapter 1: Introduces the definition of Alpha-1 Antitrypsin Drugs, market overview.
Chapter 2: Global Alpha-1 Antitrypsin Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Alpha-1 Antitrypsin Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Alpha-1 Antitrypsin Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Alpha-1 Antitrypsin Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Alpha-1 Antitrypsin Drugs Market, Global Outlook and Forecast 2023-2032 |
| Market size in 2022 |
US$ 1252.9 million
|
| Forecast Market size by 2029 |
US$ 2152.6 million
|
| Growth Rate |
CAGR of 8.0% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
79 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Alpha-1 Antitrypsin Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Alpha-1 Antitrypsin Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Alpha-1 Antitrypsin Drugs Overall Market Size
2.1 Global Alpha-1 Antitrypsin Drugs Market Size: 2022 VS 2032
2.2 Global Alpha-1 Antitrypsin Drugs Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Alpha-1 Antitrypsin Drugs Sales: 2018-2032
3 Company Landscape
3.1 Top Alpha-1 Antitrypsin Drugs Players in Global Market
3.2 Top Global Alpha-1 Antitrypsin Drugs Companies Ranked by Revenue
3.3 Global Alpha-1 Antitrypsin Drugs Revenue by Companies
3.4 Global Alpha-1 Antitrypsin Drugs Sales by Companies
3.5 Global Alpha-1 Antitrypsin Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Alpha-1 Antitrypsin Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Alpha-1 Antitrypsin Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Alpha-1 Antitrypsin Drugs Players in Global Market
3.8.1 List of Global Tier 1 Alpha-1 Antitrypsin Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Alpha-1 Antitrypsin Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Alpha-1 Antitrypsin Drugs Market Size Markets, 2022 & 2032
4.1.2 Parenteral
4.1.3 Inhalation
4.2 By Type - Global Alpha-1 Antitrypsin Drugs Revenue & Forecasts
4.2.1 By Type - Global Alpha-1 Antitrypsin Drugs Revenue, 2018-2023
4.2.2 By Type - Global Alpha-1 Antitrypsin Drugs Revenue, 2024-2032
4.2.3 By Type - Global Alpha-1 Antitrypsin Drugs Revenue Market Share, 2018-2032
4.3 By Type - Global Alpha-1 Antitrypsin Drugs Sales & Forecasts
4.3.1 By Type - Global Alpha-1 Antitrypsin Drugs Sales, 2018-2023
4.3.2 By Type - Global Alpha-1 Antitrypsin Drugs Sales, 2024-2032
4.3.3 By Type - Global Alpha-1 Antitrypsin Drugs Sales Market Share, 2018-2032
4.4 By Type - Global Alpha-1 Antitrypsin Drugs Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Alpha-1 Antitrypsin Drugs Market Size, 2022 & 2032
5.1.2 Drugstore
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Alpha-1 Antitrypsin Drugs Revenue & Forecasts
5.2.1 By Application - Global Alpha-1 Antitrypsin Drugs Revenue, 2018-2023
5.2.2 By Application - Global Alpha-1 Antitrypsin Drugs Revenue, 2024-2032
5.2.3 By Application - Global Alpha-1 Antitrypsin Drugs Revenue Market Share, 2018-2032
5.3 By Application - Global Alpha-1 Antitrypsin Drugs Sales & Forecasts
5.3.1 By Application - Global Alpha-1 Antitrypsin Drugs Sales, 2018-2023
5.3.2 By Application - Global Alpha-1 Antitrypsin Drugs Sales, 2024-2032
5.3.3 By Application - Global Alpha-1 Antitrypsin Drugs Sales Market Share, 2018-2032
5.4 By Application - Global Alpha-1 Antitrypsin Drugs Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Alpha-1 Antitrypsin Drugs Market Size, 2022 & 2032
6.2 By Region - Global Alpha-1 Antitrypsin Drugs Revenue & Forecasts
6.2.1 By Region - Global Alpha-1 Antitrypsin Drugs Revenue, 2018-2023
6.2.2 By Region - Global Alpha-1 Antitrypsin Drugs Revenue, 2024-2032
6.2.3 By Region - Global Alpha-1 Antitrypsin Drugs Revenue Market Share, 2018-2032
6.3 By Region - Global Alpha-1 Antitrypsin Drugs Sales & Forecasts
6.3.1 By Region - Global Alpha-1 Antitrypsin Drugs Sales, 2018-2023
6.3.2 By Region - Global Alpha-1 Antitrypsin Drugs Sales, 2024-2032
6.3.3 By Region - Global Alpha-1 Antitrypsin Drugs Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Alpha-1 Antitrypsin Drugs Revenue, 2018-2032
6.4.2 By Country - North America Alpha-1 Antitrypsin Drugs Sales, 2018-2032
6.4.3 US Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
6.4.4 Canada Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
6.4.5 Mexico Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Alpha-1 Antitrypsin Drugs Revenue, 2018-2032
6.5.2 By Country - Europe Alpha-1 Antitrypsin Drugs Sales, 2018-2032
6.5.3 Germany Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
6.5.4 France Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
6.5.5 U.K. Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
6.5.6 Italy Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
6.5.7 Russia Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
6.5.8 Nordic Countries Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
6.5.9 Benelux Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Alpha-1 Antitrypsin Drugs Revenue, 2018-2032
6.6.2 By Region - Asia Alpha-1 Antitrypsin Drugs Sales, 2018-2032
6.6.3 China Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
6.6.4 Japan Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
6.6.5 South Korea Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
6.6.6 Southeast Asia Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
6.6.7 India Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Alpha-1 Antitrypsin Drugs Revenue, 2018-2032
6.7.2 By Country - South America Alpha-1 Antitrypsin Drugs Sales, 2018-2032
6.7.3 Brazil Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
6.7.4 Argentina Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Alpha-1 Antitrypsin Drugs Sales, 2018-2032
6.8.3 Turkey Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
6.8.4 Israel Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
6.8.5 Saudi Arabia Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
6.8.6 UAE Alpha-1 Antitrypsin Drugs Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 Baxter
7.1.1 Baxter Company Summary
7.1.2 Baxter Business Overview
7.1.3 Baxter Alpha-1 Antitrypsin Drugs Major Product Offerings
7.1.4 Baxter Alpha-1 Antitrypsin Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Baxter Key News & Latest Developments
7.2 CSL Behring
7.2.1 CSL Behring Company Summary
7.2.2 CSL Behring Business Overview
7.2.3 CSL Behring Alpha-1 Antitrypsin Drugs Major Product Offerings
7.2.4 CSL Behring Alpha-1 Antitrypsin Drugs Sales and Revenue in Global (2018-2023)
7.2.5 CSL Behring Key News & Latest Developments
7.3 Grifols
7.3.1 Grifols Company Summary
7.3.2 Grifols Business Overview
7.3.3 Grifols Alpha-1 Antitrypsin Drugs Major Product Offerings
7.3.4 Grifols Alpha-1 Antitrypsin Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Grifols Key News & Latest Developments
7.4 Kamada
7.4.1 Kamada Company Summary
7.4.2 Kamada Business Overview
7.4.3 Kamada Alpha-1 Antitrypsin Drugs Major Product Offerings
7.4.4 Kamada Alpha-1 Antitrypsin Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Kamada Key News & Latest Developments
7.5 Abeona Therapeutics
7.5.1 Abeona Therapeutics Company Summary
7.5.2 Abeona Therapeutics Business Overview
7.5.3 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Major Product Offerings
7.5.4 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Abeona Therapeutics Key News & Latest Developments
7.6 Alnylam Pharmaceuticals
7.6.1 Alnylam Pharmaceuticals Company Summary
7.6.2 Alnylam Pharmaceuticals Business Overview
7.6.3 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Major Product Offerings
7.6.4 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.7 Applied Genetic Technologies Corp
7.7.1 Applied Genetic Technologies Corp Company Summary
7.7.2 Applied Genetic Technologies Corp Business Overview
7.7.3 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Major Product Offerings
7.7.4 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Applied Genetic Technologies Corp Key News & Latest Developments
7.8 Arrowhead Research Corporation
7.8.1 Arrowhead Research Corporation Company Summary
7.8.2 Arrowhead Research Corporation Business Overview
7.8.3 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Major Product Offerings
7.8.4 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Arrowhead Research Corporation Key News & Latest Developments
7.9 Baxalta
7.9.1 Baxalta Company Summary
7.9.2 Baxalta Business Overview
7.9.3 Baxalta Alpha-1 Antitrypsin Drugs Major Product Offerings
7.9.4 Baxalta Alpha-1 Antitrypsin Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Baxalta Key News & Latest Developments
8 Global Alpha-1 Antitrypsin Drugs Production Capacity, Analysis
8.1 Global Alpha-1 Antitrypsin Drugs Production Capacity, 2018-2032
8.2 Alpha-1 Antitrypsin Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Alpha-1 Antitrypsin Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Alpha-1 Antitrypsin Drugs Supply Chain Analysis
10.1 Alpha-1 Antitrypsin Drugs Industry Value Chain
10.2 Alpha-1 Antitrypsin Drugs Upstream Market
10.3 Alpha-1 Antitrypsin Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Alpha-1 Antitrypsin Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Alpha-1 Antitrypsin Drugs in Global Market
Table 2. Top Alpha-1 Antitrypsin Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Alpha-1 Antitrypsin Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Alpha-1 Antitrypsin Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Alpha-1 Antitrypsin Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Alpha-1 Antitrypsin Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Alpha-1 Antitrypsin Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Alpha-1 Antitrypsin Drugs Product Type
Table 9. List of Global Tier 1 Alpha-1 Antitrypsin Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alpha-1 Antitrypsin Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Alpha-1 Antitrypsin Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Alpha-1 Antitrypsin Drugs Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Alpha-1 Antitrypsin Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Alpha-1 Antitrypsin Drugs Sales (K Units), 2024-2032
Table 16. By Application ? Global Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Alpha-1 Antitrypsin Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Alpha-1 Antitrypsin Drugs Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Alpha-1 Antitrypsin Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Alpha-1 Antitrypsin Drugs Sales (K Units), 2024-2032
Table 21. By Region ? Global Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Alpha-1 Antitrypsin Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Alpha-1 Antitrypsin Drugs Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Alpha-1 Antitrypsin Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Alpha-1 Antitrypsin Drugs Sales (K Units), 2024-2032
Table 26. By Country - North America Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Alpha-1 Antitrypsin Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Alpha-1 Antitrypsin Drugs Sales, (K Units), 2024-2032
Table 30. By Country - Europe Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Alpha-1 Antitrypsin Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Alpha-1 Antitrypsin Drugs Sales, (K Units), 2024-2032
Table 34. By Region - Asia Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Alpha-1 Antitrypsin Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Alpha-1 Antitrypsin Drugs Sales, (K Units), 2024-2032
Table 38. By Country - South America Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Alpha-1 Antitrypsin Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Alpha-1 Antitrypsin Drugs Sales, (K Units), 2024-2032
Table 42. By Country - Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Alpha-1 Antitrypsin Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Alpha-1 Antitrypsin Drugs Sales, (K Units), 2024-2032
Table 46. Baxter Company Summary
Table 47. Baxter Alpha-1 Antitrypsin Drugs Product Offerings
Table 48. Baxter Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Baxter Key News & Latest Developments
Table 50. CSL Behring Company Summary
Table 51. CSL Behring Alpha-1 Antitrypsin Drugs Product Offerings
Table 52. CSL Behring Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. CSL Behring Key News & Latest Developments
Table 54. Grifols Company Summary
Table 55. Grifols Alpha-1 Antitrypsin Drugs Product Offerings
Table 56. Grifols Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Grifols Key News & Latest Developments
Table 58. Kamada Company Summary
Table 59. Kamada Alpha-1 Antitrypsin Drugs Product Offerings
Table 60. Kamada Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Kamada Key News & Latest Developments
Table 62. Abeona Therapeutics Company Summary
Table 63. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Offerings
Table 64. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Abeona Therapeutics Key News & Latest Developments
Table 66. Alnylam Pharmaceuticals Company Summary
Table 67. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Offerings
Table 68. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Alnylam Pharmaceuticals Key News & Latest Developments
Table 70. Applied Genetic Technologies Corp Company Summary
Table 71. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Offerings
Table 72. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Applied Genetic Technologies Corp Key News & Latest Developments
Table 74. Arrowhead Research Corporation Company Summary
Table 75. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Offerings
Table 76. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Arrowhead Research Corporation Key News & Latest Developments
Table 78. Baxalta Company Summary
Table 79. Baxalta Alpha-1 Antitrypsin Drugs Product Offerings
Table 80. Baxalta Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Baxalta Key News & Latest Developments
Table 82. Alpha-1 Antitrypsin Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Alpha-1 Antitrypsin Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Alpha-1 Antitrypsin Drugs Production by Region, 2018-2023 (K Units)
Table 85. Global Alpha-1 Antitrypsin Drugs Production by Region, 2024-2032 (K Units)
Table 86. Alpha-1 Antitrypsin Drugs Market Opportunities & Trends in Global Market
Table 87. Alpha-1 Antitrypsin Drugs Market Drivers in Global Market
Table 88. Alpha-1 Antitrypsin Drugs Market Restraints in Global Market
Table 89. Alpha-1 Antitrypsin Drugs Raw Materials
Table 90. Alpha-1 Antitrypsin Drugs Raw Materials Suppliers in Global Market
Table 91. Typical Alpha-1 Antitrypsin Drugs Downstream
Table 92. Alpha-1 Antitrypsin Drugs Downstream Clients in Global Market
Table 93. Alpha-1 Antitrypsin Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Alpha-1 Antitrypsin Drugs Segment by Type in 2022
Figure 2. Alpha-1 Antitrypsin Drugs Segment by Application in 2022
Figure 3. Global Alpha-1 Antitrypsin Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Alpha-1 Antitrypsin Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Alpha-1 Antitrypsin Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. Alpha-1 Antitrypsin Drugs Sales in Global Market: 2018-2032 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Alpha-1 Antitrypsin Drugs Revenue in 2022
Figure 9. By Type - Global Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Alpha-1 Antitrypsin Drugs Revenue Market Share, 2018-2032
Figure 11. By Type - Global Alpha-1 Antitrypsin Drugs Sales Market Share, 2018-2032
Figure 12. By Type - Global Alpha-1 Antitrypsin Drugs Price (USD/Unit), 2018-2032
Figure 13. By Application - Global Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Alpha-1 Antitrypsin Drugs Revenue Market Share, 2018-2032
Figure 15. By Application - Global Alpha-1 Antitrypsin Drugs Sales Market Share, 2018-2032
Figure 16. By Application - Global Alpha-1 Antitrypsin Drugs Price (USD/Unit), 2018-2032
Figure 17. By Region - Global Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Alpha-1 Antitrypsin Drugs Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Alpha-1 Antitrypsin Drugs Revenue Market Share, 2018-2032
Figure 20. By Region - Global Alpha-1 Antitrypsin Drugs Sales Market Share, 2018-2032
Figure 21. By Country - North America Alpha-1 Antitrypsin Drugs Revenue Market Share, 2018-2032
Figure 22. By Country - North America Alpha-1 Antitrypsin Drugs Sales Market Share, 2018-2032
Figure 23. US Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Alpha-1 Antitrypsin Drugs Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Alpha-1 Antitrypsin Drugs Sales Market Share, 2018-2032
Figure 28. Germany Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. France Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Alpha-1 Antitrypsin Drugs Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Alpha-1 Antitrypsin Drugs Sales Market Share, 2018-2032
Figure 37. China Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. India Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Alpha-1 Antitrypsin Drugs Revenue Market Share, 2018-2032
Figure 43. By Country - South America Alpha-1 Antitrypsin Drugs Sales Market Share, 2018-2032
Figure 44. Brazil Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Alpha-1 Antitrypsin Drugs Sales Market Share, 2018-2032
Figure 48. Turkey Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Alpha-1 Antitrypsin Drugs Revenue, (US$, Mn), 2018-2032
Figure 52. Global Alpha-1 Antitrypsin Drugs Production Capacity (K Units), 2018-2032
Figure 53. The Percentage of Production Alpha-1 Antitrypsin Drugs by Region, 2022 VS 2032
Figure 54. Alpha-1 Antitrypsin Drugs Industry Value Chain
Figure 55. Marketing Channels
